References
- Gross NJ. The COPD Pipeline X. COPD 2011; 8:244–247.
- Franciosi L, A dual PDE3/4 inhibitor is well tolerated and maintains bronchodilator activity when administered by inhalation to mild-to-moderate asthmatics on 2 consecutive days. Am J Respir Crit Care Med 2013; 187:A3875.
- Bickston SJ, Tetomilast: new promise for phosphodiesterase-4 inhibitors? Expert Opin Invest Drugs 2012; 21:1845–1849. doi: 10.1517/13543784.2012.732065.
- Li J, A myristoylated alanine-richC kinase substrate-related peptide suppresses cytokine mRNA and protein expression in LPS-activated canine neutrophils. Am J Respir Cell Mol Biol 2013; 48:314–321. doi:10.1165/rcmb.2012-0278OC.